217 related articles for article (PubMed ID: 34500777)
1. Discrimination of Methionine Sulfoxide and Sulfone by Human Neutrophil Elastase.
Leahy D; Grant C; Jackson A; Duff A; Tardiota N; Van Haeften J; Chen X; Peake JM; Kruppa MD; Smith ET; Johnson DA; Lott WB; Harris JM
Molecules; 2021 Sep; 26(17):. PubMed ID: 34500777
[TBL] [Abstract][Full Text] [Related]
2. TAILS proteomics reveals dynamic changes in airway proteolysis controlling protease activity and innate immunity during COPD exacerbations.
Mallia-Milanes B; Dufour A; Philp C; Solis N; Klein T; Fischer M; Bolton CE; Shapiro S; Overall CM; Johnson SR
Am J Physiol Lung Cell Mol Physiol; 2018 Dec; 315(6):L1003-L1014. PubMed ID: 30284925
[TBL] [Abstract][Full Text] [Related]
3. Extended Cleavage Specificity of Human Neutrophil Elastase, Human Proteinase 3, and Their Distant Ortholog Clawed Frog PR3-Three Elastases With Similar Primary but Different Extended Specificities and Stability.
Fu Z; Thorpe M; Akula S; Chahal G; Hellman LT
Front Immunol; 2018; 9():2387. PubMed ID: 30459762
[TBL] [Abstract][Full Text] [Related]
4. Paucimannose-Rich
Loke I; Østergaard O; Heegaard NHH; Packer NH; Thaysen-Andersen M
Mol Cell Proteomics; 2017 Aug; 16(8):1507-1527. PubMed ID: 28630087
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of neutrophil elastase by alpha1-protease inhibitor at the surface of human polymorphonuclear neutrophils.
Korkmaz B; Attucci S; Jourdan ML; Juliano L; Gauthier F
J Immunol; 2005 Sep; 175(5):3329-38. PubMed ID: 16116225
[TBL] [Abstract][Full Text] [Related]
6. Discriminating between the activities of human neutrophil elastase and proteinase 3 using serpin-derived fluorogenic substrates.
Korkmaz B; Attucci S; Hazouard E; Ferrandiere M; Jourdan ML; Brillard-Bourdet M; Juliano L; Gauthier F
J Biol Chem; 2002 Oct; 277(42):39074-81. PubMed ID: 12114510
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil elastase inhibitors as treatment for COPD.
Ohbayashi H
Expert Opin Investig Drugs; 2002 Jul; 11(7):965-80. PubMed ID: 12084007
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of aptameric inhibitors of human neutrophil elastase.
Malicki S; Książek M; Sochaj Gregorczyk A; Kamińska M; Golda A; Chruścicka B; Mizgalska D; Potempa J; Marti HP; Kozieł J; Wieczorek M; Pieczykolan J; Mydel P; Dubin G
J Biol Chem; 2023 Aug; 299(8):104889. PubMed ID: 37286041
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil Extracellular Traps (NETs) in Severe SARS-CoV-2 Lung Disease.
Szturmowicz M; Demkow U
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445556
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil elastase (NE) and NE inhibitors: canonical and noncanonical functions in lung chronic inflammatory diseases (cystic fibrosis and chronic obstructive pulmonary disease).
Roghanian A; Sallenave JM
J Aerosol Med Pulm Drug Deliv; 2008 Mar; 21(1):125-44. PubMed ID: 18518838
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil elastase cleaves epithelial cadherin in acutely injured lung epithelium.
Boxio R; Wartelle J; Nawrocki-Raby B; Lagrange B; Malleret L; Hirche T; Taggart C; Pacheco Y; Devouassoux G; Bentaher A
Respir Res; 2016 Oct; 17(1):129. PubMed ID: 27751187
[TBL] [Abstract][Full Text] [Related]
12. Autoprocessing of neutrophil elastase near its active site reduces the efficiency of natural and synthetic elastase inhibitors.
Dau T; Sarker RS; Yildirim AO; Eickelberg O; Jenne DE
Nat Commun; 2015 Apr; 6():6722. PubMed ID: 25857284
[TBL] [Abstract][Full Text] [Related]
13. EPI-hNE4, a proteolysis-resistant inhibitor of human neutrophil elastase and potential anti-inflammatory drug for treating cystic fibrosis.
Attucci S; Gauthier A; Korkmaz B; Delépine P; Martino MF; Saudubray F; Diot P; Gauthier F
J Pharmacol Exp Ther; 2006 Aug; 318(2):803-9. PubMed ID: 16627747
[TBL] [Abstract][Full Text] [Related]
14. Competition between elastase and related proteases from human neutrophil for binding to alpha1-protease inhibitor.
Korkmaz B; Poutrain P; Hazouard E; de Monte M; Attucci S; Gauthier FL
Am J Respir Cell Mol Biol; 2005 Jun; 32(6):553-9. PubMed ID: 15764720
[TBL] [Abstract][Full Text] [Related]
15. Preclinical evaluation of [
Estrada S; Elgland M; Selvaraju RK; Mani K; Tegler G; Wanhainen A; Wågsäter D; Bergström M; Jimenez-Royo P; Jahan M; Nordeman P; Antoni G
Nucl Med Biol; 2022; 106-107():62-71. PubMed ID: 35066391
[TBL] [Abstract][Full Text] [Related]
16. The elastase-PK101 structure: mechanism of an ultrasensitive activity-based probe revealed.
Lechtenberg BC; Kasperkiewicz P; Robinson H; Drag M; Riedl SJ
ACS Chem Biol; 2015 Apr; 10(4):945-51. PubMed ID: 25581168
[TBL] [Abstract][Full Text] [Related]
17. The neutrophil in chronic obstructive pulmonary disease.
Hoenderdos K; Condliffe A
Am J Respir Cell Mol Biol; 2013 May; 48(5):531-9. PubMed ID: 23328639
[TBL] [Abstract][Full Text] [Related]
18. Kinetics of equine neutrophil elastase release and superoxide anion generation following secretagogue activation: a potential mechanism for antiproteinase inactivation.
Dagleish MP; Pemberton AD; Brazil TJ; McAleese SM; Miller HR; Scudamore CL
Vet Immunol Immunopathol; 1999 Dec; 72(3-4):257-75. PubMed ID: 10628671
[TBL] [Abstract][Full Text] [Related]
19. Proteolytic cleavage of HLA class II by human neutrophil elastase in pneumococcal pneumonia.
Domon H; Maekawa T; Isono T; Furuta K; Kaito C; Terao Y
Sci Rep; 2021 Jan; 11(1):2432. PubMed ID: 33510372
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of an aptamer inhibitor of neutrophil elastase in lung inflammatory injury.
Bless NM; Smith D; Charlton J; Czermak BJ; Schmal H; Friedl HP; Ward PA
Curr Biol; 1997 Nov; 7(11):877-80. PubMed ID: 9382799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
